SOLACI PERIPHERAL | 2nd Clinical Case: Juxtarenal Abdominal Aortic Aneurysm

Discusión de caso clínico

SOLACI’s Department of Peripheral Endovascular Interventions brings a new challenging clinical case for the whole Latin American medical community so as to continue fostering and sharing scientific knowledge and experience among peers.

Tell us what you think about this case and its resolution using the comments section in this post, and answer the questions featured in the last part of this article.


Juxtarenal Abdominal Aortic Aneurysm


Authors: Dr. Luis R. Virgen Carrillo, MD, PhD / Dr. Carlos Salazar, MD / Dr. Rodolfo Siordia Zamorano, MD.

E-mail: drvirgen@cardiovascular.mx; Twitter: @drluisvirgen

Institution: Virgen Cardiovascular Research, Guadalajara, Mexico, & Cirujanos Cardiovasculares del Noroeste.


– Male patient, 61 years old, anesthesiologist, cigarette smoker, hypertensive. He begins experiencing intense abdominal pain. Hb reduction, 14-11 g/dL. He is hemodynamically stable; blood pressure 110/60 mmHg, heart rate 68 bpm. An abdominal computed tomography angiography shows the contained rupture of an abdominal aneurysm. Anatomy: juxtarenal aneurysm without neck, with small, tortuous iliac arteries.

Caso SOLACI PERIPHERAL - Aneurisma de Aorta Abdominal Yuxtarrenal


Case Resolution

– The algorithm for the attention of patients with suspected abdominal aneurysm rupture is activated. Physicians choose a percutaneous endovascular treatment (the chimney technique [chEVAR]).

Caso Clínico SOLACI Peripheral

– The procedure is conducted in a hybrid cath lab; bilateral femoral artery puncture, guided by ultrasound and image fusion. Two Perclose devices are used in each femoral artery. Both brachial arteries are dissected; an 8-Fr flexor introducer sheath is placed inside each renal artery. Selective renal artery catheterization and stenting using an 8×39 film-coated BeGraft (Bentley Innomed GmbH, Hechingen, Germany). A parallel 0.035” Magic Torque guidewire ×260 cm is used. Then, an Ovation 26 Abdominal Stent Graft System (Endologix, California, USA), 14-15 Fr OD, is used. The device is placed using image fusion, the fill polymer is delivered, and both BeGraft stents are implanted. After the procedure, there is a type Ia endoleak in peri-chimney spaces (“gutters”). New dilation conducted with partial improvement. A decision is made to conduct an embolization with an Onix device at a second instance.

– The patient is stable and does not experience pain. An ultrasound is conducted within 24 hours: no flow in the aneurysm sac.

2° Caso SOLACI Peripheral Aneurisma de aorta abdominal yuxtarrenal

– A computed tomography angiography is conducted at 72 hours, 1, 6, and 12 months; no endoleaks. (VIDEO #2)


Questions

  1. Is there an algorithm for the attention of patients with suspected abdominal aneurysm rupture at your site?
  2. In your opinion, what is the best option for a patient with aneurysm rupture: surgical treatment or endovascular treatment?
  3. What is your treatment of choice for para/juxtarenal aneurysms?
  4. Should type I endoleaks be treated in the cath lab?

Join the conversation through the comments in this post!


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

SELUTION Sirolimus-Eluting Balloon For De Novo Coronary Lesions – New Evidence and Clinical Perspectives

The Latin American Society of Interventional Cardiology invites you to join a new virtual scientific event focused on the latest evidence and clinical perspectives...

Impact of Baseline Systolic Blood Pressure on Blood Pressure Changes Following Renal Denervation

Renal denervation (RDN) is a guideline-recommended therapy to reduce blood pressure in patients with uncontrolled hypertension, although uncertainties remain regarding which factors best predict...

Hypertriglyceridemia as Key Factor to Abdominal Aortic Aneurysm Development and Rupture: Genetic and Experimental Evidence

Abdominal aortic aneurysm (AAA) is a deadly vascular disease with no effective drug treatment, and risk of rupture reaching up to 80%. Even though...

Atrial Fibrillation and Chronic Kidney Disease: Outcomes of Different Stroke Prevention Strategies

Atrial fibrillation (AF) affects approximately 1 in every 4 patients with end-stage renal disease (ESRD). This population carries a high burden of comorbidities and...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Impact of Baseline Systolic Blood Pressure on Blood Pressure Changes Following Renal Denervation

Renal denervation (RDN) is a guideline-recommended therapy to reduce blood pressure in patients with uncontrolled hypertension, although uncertainties remain regarding which factors best predict...

AHA 2025 | OPTIMA-AF: 1 Month vs. 12 Months of Dual Therapy (DOAC + P2Y12) After PCI in Atrial Fibrillation

Concomitant atrial fibrillation (AF) and coronary artery disease is a common occurrence in clinical practice. In these patients, current guidelines recommend 1 month of...

AHA 2025 | CLOSURE-AF: Left Atrial Appendage Occlusion (LAAO) vs. Medical Therapy in Atrial Fibrillation with High Stroke and Bleeding Risk

Atrial fibrillation (AF) is a complex condition in which patients often present with multiple comorbidities, including high bleeding risk. Percutaneous left atrial appendage occlusion...